Diagnostic Value of Spectral Doppler Ultrasound in Detecting Breast Malignancies: An Original Article


Elham Keshavarz 1 , Mohammad Zare Mehrjardi ORCID 2 , 3 , * , Mohammad Ali Karimi 4 , Nourollah Valian 1 , Mojgan Kalantari 1 , Kobra Valian 5

1 Radiologist, Department of Radiology, Mahdieh Women’s Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

2 Radiologist, (ORCID iD: 0000-0001-5793-5323), Department of Radiology, Shohada Tajrish Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

3 Clinical Researcher (ORCID iD: 0000-0001-5793-5323), Section of Breast Imaging, Division of Clinical Research, Climax Radiology Education Foundation, Tehran, IR Iran

4 Radiologist, Department of Radiology, Modarres Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 Lecturer, Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, IR Iran

How to Cite: Keshavarz E, Zare Mehrjardi M, Karimi M A, Valian N, Kalantari M, et al. Diagnostic Value of Spectral Doppler Ultrasound in Detecting Breast Malignancies: An Original Article, Int J Cancer Manag. 2018 ; 11(2):e8200. doi: 10.5812/ijcm.8200.


International Journal of Cancer Management: 11 (2); e8200
Published Online: February 18, 2018
Article Type: Research Article
Received: August 9, 2016
Revised: February 7, 2017
Accepted: February 5, 2018


Background: The present study was conducted to investigate the diagnostic value of spectral Doppler ultrasound in determining malignant potential of breast masses.

Methods: The dedicated B-mode and Doppler (including color and spectral) breast ultrasound examinations were performed on 100 consecutive women with breast mass (mean age = 45.02 years). The findings were compared between benign (n = 65) and malignant (n = 35) groups, regarding the histopathologic results. Receiver operating characteristic (ROC) curve was used to determine the optimal cut-off point for each spectral Doppler index.

Results: On B-mode ultrasound, malignant breast masses tended to have bigger size, irregular and ill-defined border, cystic components, and mixed echogenicity (P < 0.001 for all characteristics). On color Doppler study, detectable flow was more common in malignant tumors compared to benign lesions (74.1% vs. 21.9%, P < 0.0001). All spectral Doppler indices, including mean peak systolic velocity (PSV), resistive index (RI), and pulsatility index (PI) were significantly higher in malignant tumors. All of these indices had high diagnostic accuracy for differentiating malignant tumors from benign lesions with area under the curve (AUC) equals to 0.79, 0.78, and 0.90 for PSV, RI, and PI, respectively. The optimal cut-off points were PSV = 12.5 cm/s (sensitivity: 75%, specificity: 71.4%), RI = 0.68 (sensitivity = 85%, specificity = 74%), and PI = 0.93 (sensitivity = 90%, specificity = 85.7%).

Conclusions: Doppler examination has a significant role in the evaluation of breast masses and adds value to the B-mode ultrasound for distinguishing malignant tumors from benign lesions.

1. Background

Breast cancer is the most prevalent malignancy among women (1, 2). Timely and proper diagnosis of breast malignancies is of critical importance. In general, masses with cystic and solid components, irregular contour, micro-calcification, or other non-reassuring findings on B-mode ultrasound examination are considered potentially malignant and planned to be biopsied. Doppler ultrasound (including color and spectral methods) can help to differentiate benign masses from malignant tumors. This technique may obviate the need for biopsy in some suspicious lesions (3-9).

Color Doppler can recognize neovascularization, which may be used as a clue for detecting malignant lesions (5-10). The findings of color Doppler studies, however, may be overlapped in highly vascular benign masses and malignant neoplasms (11). This overlap makes it difficult to differentiate malignant tumors from benign masses just based on color Doppler features. However, it seems that the combination of B-mode ultrasound and Doppler study may increase the sensitivity and specificity of ultrasound examination for detecting breast masses with high probability of malignancy. In addition, awareness of the vascularization status of the lesion is valuable for making decision upon performing neoadjuvant chemotherapy, and monitoring response to the treatment (12).

Currently, spectral Doppler parameters are not considered in many imaging centers as a part of routine breast ultrasound examination in the daily practice. The investigations on the applications of spectral Doppler for breast mass evaluation are limited, and entail inconsistent results. The aim of this study was to assess whether the features of breast masses on spectral Doppler examination may help identify the nature of the lesion as well as to determine the optimal cut-off points for each spectral index.

2. Methods

2.1. Approvals

The research proposal was approved by “Institutional Review Board” and “Research Ethics Committee” of Shahid Beheshti University of Medical Sciences, Tehran, Iran. In addition, informed consent was obtained from all participants.

2.2. Study Design

This analytic cross sectional (diagnostic) study was conducted on 100 consecutive women with breast masses that were nominated to undergo core-needle biopsy. The patients were included in the study prospectively with convenience sampling during 12 months (from February 2014 to February 2015). The exclusion criteria were the patient unwillingness and loss of follow-up. The mean age of patients was 45.02 ± 11.88 years (range: 20 - 81 years).

2.3. Data Recording

The findings of B-mode ultrasound (size, margin, content, and echopattern of masses) were recorded according to the breast imaging-reporting and data system (BI-RADS) for mammography and ultrasound (2013 updated version, 5th edition). Color and spectral Doppler features (the presence or absence of blood flow, central or peripheral distribution of flow, resistive index [RI], pulsatility index [PI], and peak systolic velocity [PSV]) were also recorded for each patient. The color Doppler study was optimized by modifying ultrasound machine settings for each individual patient, and spectral Doppler parameters were obtained via manual tracing of 1 to 3 contiguous recorded waveforms.

All examinations and measurements were performed by a radiologist with 15 years of experience in breast imaging in a tertiary care referral center (Mahdieh Women’s Hospital, Tehran, Iran) just before core-needle biopsy of the mass. All of the patients were examined, utilizing a 5- to 9-MHz linear array transducer (Accuvix V10, Samsung-Medison, Seoul, Korea).

Histopathologic results were considered as the gold-standard for classifying masses into benign and malignant groups.

2.4. Statistical Analysis

For statistical analysis, the software SPSS version 20.0 for windows (SPSS Inc., Chicago, IL) was used. The results were presented as mean ± standard deviation (SD) for quantitative variables, and summarized by absolute frequencies as percentages for categorical variables. Continuous variables were compared using t test or non-parametric Mann-Whitney U test. Categorical variables were compared, using Chi-square test or Fisher's exact test. P-values of 0.05 or less were considered statistically significant.

Receiver operating characteristic (ROC) curve was used to identify the optimal cut-off points for PSV, RI, and PI to discriminate malignant from benign masses with the highest sensitivity and specificity.

3. Results

The comparison of B-mode and Doppler ultrasound findings of benign and malignant masses is summarized in Table 1 and some sample ultrasound images are shown in Figures 1 to 3 .

Table 1. Comparison of B-Mode and Doppler Ultrasound Characteristics of Benign and Malignant Breast Massesa
Ultrasonographic FeatureBenignMalignantP Value
Size, mm17.05 ± 4.8024.67 ± 9.03< 0.001
Margin< 0.001
Echogenicity< 0.001
Flow< 0.0001
Flow pattern (If present)< 0.001
Peripheral (Rim)78.546.2
Central (Internal)21.553.8
PSV, cm/s11.69 ± 3.3018.90 ± 10.400.012
RI0.63 ± 0.070.73 ± 0.090.001
PI0.90 ± 0.401.09 ± 0.200.001

Abbreviations: PI, pulsatility index; RI, resistive index; PSV, peak systolic velocity.

aValues are expressed as mean ± SD or %.

Figure 1. Invasive ductal carcinoma. A, B-mode ultrasound reveals a large lobulated mixed-echo mass in the right breast of a 60-year-old woman; B, On color Doppler study, the mass shows mainly peripheral flow. Spectral indices were PSV = 24 cm/s, RI = 0.8, and PI = 1.2. PSV, peak systolic velocity; RI, resistive index; PI, pulsatility index.
Figure 2. Invasive ductal carcinoma in the right breast of a 61-year-old woman. An irregular, lobulated solid mass is seen with both central and peripheral flow. Spectral indices were PSV = 23 cm/s, RI = 0.74, and PI = 1.01. PSV, peak systolic velocity; RI, resistive index; PI, pulsatility index.
Figure 3. Fibroadenolipoma in a 33-year-old woman. A well-defined oval-shaped mass with mixed echogenicity is seen with no flow on color Doppler examination.

3.1. Histopathologic Results

According to the histopathologic examinations, 65 patients had benign and 35 patients had malignant breast masses. Malignant lesions were invasive ductal carcinoma (n = 25), ductal carcinoma in situ (n = 8), and invasive lobular carcinoma (n = 2) histologically. Benign masses included fibrocystic changes (n = 22), sclerosing adenosis (n = 14), fibroadenoma (n = 10), nonspecific adipose tissue (n = 10), mastitis (n = 4), lactation-related changes (n = 4), and intramammary lymph node (n = 1).

3.2. B-Mode Ultrasound

The comparison of B-mode ultrasound findings revealed that solid-cystic component, not-circumscribed margin, and mixed echogenicity were significantly more common in malignant tumors compared to the benign lesions (Table 1).

3.3. Color Doppler Study

On color Doppler study, 74.3% of malignant tumors showed detectable flow, while blood flow was seen in 21.5% of benign lesions (P < 0.0001). The flow pattern was mainly central (i.e., internal vascularity) in malignant tumors, and peripheral (i.e., vessels in rim) in benign masses (P< 0.001).

3.4. Spectral Doppler study

On spectral analysis, the mean PSV was significantly higher in malignant masses compared to the benign lesions (18.90 ± 10.40 cm/s versus 11.69 ± 3.30 cm/s; P = 0.012). Similarly, the mean RI (0.73 ± 0.09 versus 0.63 ± 0.07; P = 0.001), and the mean PI (1.09 ± 0.20 versus 0.9 ± 0.04; P = 0.001) were significantly higher in malignant tumors.

To determine the diagnostic accuracy of spectral Doppler indices for differentiating malignant tumors from benign lesions, we found that all 3 indices, i.e. PSV (AUC = 0.786), RI (AUC = 0.779), and PI (AUC = 0.900), were highly capable to distinguish malignant from benign lesions (Figure 4). The optimal cut-off points for PSV, RI, and PI were 12.5 cm/s (sensitivity = 75%, and specificity = 71.4%), 0.68 (sensitivity = 85%, and specificity = 71.4%), and 0.93 (sensitivity = 90%, and specificity = 85.7%), respectively.

Figure 4. Receiver operating characteristic (ROC) curves of PSV A, RI B, and PI C show significant areas under the curve (AUC) for all of these spectral Doppler indices. PSV, peak systolic velocity; RI, resistive index; PI, pulsatility index.

4. Discussion

In the present study, the comparison of B-mode ultrasound findings between malignant and benign lesions revealed that malignant tumors were much larger. In addition, the main characteristics of malignant tumors included not-circumscribed margin, solid-cystic component, and mixed echogenicity. These findings are consistent with previous studies (1-3, 11).

Color Doppler helps to detect neovascularization in malignant tumors and may help to distinguish them from benign breast masses (5-10). In the present study, hypervascularity and detectable flow were more common in the malignant lesions. Similarly, in a study conducted by Grischke et al. central blood flow was detectable in 71% and 6.6% of malignant and benign breast masses, respectively (8). The positive predictive value (PPV) for malignancy detection based on the combination of breast B-mode ultrasound findings and color Doppler patterns was reported 92% (9). A lesion vascularization status can be an indicator of malignant potential, metastasis potential, and invasiveness. Moreover, it may provide information about response to treatment and prognosis. Lee et al. studied 52 malignant tumors and 32 benign breast lesions, and found that the presence of high-flow in the early stages of breast tumor is associated with the higher probability of metastasis to the axillary lymph-nodes (5). It was classically thought that malignant breast tumors have stronger color Doppler signals compared to benign lesions (13, 14). However, subsequent studies showed that this is not always true. In general, vascularization is increased in high-grade high-cellular malignant tumors, which have special feeding vessels helping them grow and invade, while low-grade malignant tumors may have no detectable vascularity on color Doppler examination (11, 12). On the other hand, some studies have reported that there is an overlap in color Doppler findings of hypervascular benign masses and malignant tumors (11). This is not unusual, and makes it difficult to differentiate malignant tumors from benign lesions just based on color Doppler pattern. However, it seems that the combination of B-mode ultrasound and color Doppler findings can increase the sensitivity and specificity of ultrasound examination for determining the nature of breast tumors (12).

In this study, the mean values of PSV, RI, and PI were significantly higher in malignant tumors compared to benign lesions. In addition, all of these indices, particularly PI, had high sensitivity and specificity for differentiating malignancies from benign lesions. The findings of this study are similar to some previous studies. For example, Chao et al. reported that PSV, RI, and PI are higher in carcinomas; however, unlike our investigation, they did not find any cut-off point to distinct benign and malignant tumors according to these characteristics (3). Studying on 70 breast masses, Stanzani et al. demonstrated that RI ≥ 0.73 is significantly predictive of malignancy (15). Grischke et al. demonstrated that the presence of blood flow in tumors is a highly specific finding (specificity: 93%) for differentiating malignant from benign breast masses. Other Doppler parameters (such as RI ≥ 0.80) minimally increased the specificity. In their study, sensitivity, specificity, and positive predictive value of Doppler examination to detect malignant breast tumors were 80%, 90%, and 93%, respectively (8).

4.1. Conclusions

In this study, we aimed at investigating the diagnostic accuracy of spectral Doppler ultrasound to determine the malignant potential of breast masses.

In conclusion, although we cannot reliably categorize a breast mass as malignant or benign only based on Doppler ultrasound, this study emphasizes that color and spectral Doppler entail additive information to B-mode ultrasound examination in order to suspect breast malignancies.

4.2. Clinical Practice Points

It was stated earlier that the blood flow pattern in breast malignant lesions is usually central (within the mass) rather than peripheral (around the mass). However, spectral Doppler indices like PSV, RI, and PI may add accuracy to suspect breast malignancies. In the present study, we investigated these indices and determined the reliable cut-off point for each one. The application of spectral Doppler besides the B-mode and color Doppler ultrasound examination may be beneficial in detecting potentially malignant tumors with higher confidence. It may prevent some unnecessary biopsies, and also can guide the treatment strategies in the future.




  • 1.

    Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151-63. doi: 10.1001/jama.299.18.2151. [PubMed: 18477782].

  • 2.

    Sickles EA. Imaging techniques other than mammography for the detection and diagnosis of breast cancer. Recent Results Cancer Res. 1990;119:127-35. [PubMed: 2236853].

  • 3.

    Chao TC, Lo YF, Chen SC, Chen MF. Color Doppler ultrasound in benign and malignant breast tumors. Breast Cancer Res Treat. 1999;57(2):193-9. [PubMed: 10598046].

  • 4.

    Dixon JM, Walsh J, Paterson D, Chetty U. Colour Doppler ultrasonography studies of benign and malignant breast lesions. Br J Surg. 1992;79(3):259-60. [PubMed: 1555096].

  • 5.

    Lee WJ, Chu JS, Houng SJ, Chung MF, Wang SM, Chen KM. Breast cancer angiogenesis: a quantitative morphologic and Doppler imaging study. Ann Surg Oncol. 1995;2(3):246-51. [PubMed: 7543800].

  • 6.

    Kumar A, Srivastava V, Singh S, Shukla RC. Color Doppler ultrasonography for treatment response prediction and evaluation in breast cancer. Future Oncol. 2010;6(8):1265-78. doi: 10.2217/fon.10.93. [PubMed: 20799873].

  • 7.

    Campi R, Carlotto M, Gorreta L, Tragni C, Belli L, Tufarulo L, et al. [The role of color Doppler echography in the diagnosis of breast tumors]. Radiol Med. 1990;79(3):182-4. [PubMed: 2186439].

  • 8.

    Grischke EM, von Fournier D, Sohn C, Wallwiener D, Bastert G. [Diagnostic value of Doppler ultrasound in evaluation of breast tumors]. Zentralbl Gynakol. 1996;118(10):553-9. [PubMed: 8999709].

  • 9.

    McNicholas MM, Mercer PM, Miller JC, McDermott EW, O'Higgins NJ, MacErlean DP. Color Doppler sonography in the evaluation of palpable breast masses. AJR Am J Roentgenol. 1993;161(4):765-71. doi: 10.2214/ajr.161.4.8372754. [PubMed: 8372754].

  • 10.

    del Cura JL, Elizagaray E, Zabala R, Legorburu A, Grande D. The use of unenhanced Doppler sonography in the evaluation of solid breast lesions. AJR Am J Roentgenol. 2005;184(6):1788-94. doi: 10.2214/ajr.184.6.01841788. [PubMed: 15908531].

  • 11.

    Svensson WE, Pandian AJ, Hashimoto H. The use of breast ultrasound color Doppler vascular pattern morphology improves diagnostic sensitivity with minimal change in specificity. Ultraschall Med. 2010;31(5):466-74. doi: 10.1055/s-0028-1109478. [PubMed: 20094978].

  • 12.

    Busilacchi P, Draghi F, Preda L, Ferranti C. Has color Doppler a role in the evaluation of mammary lesions?. J Ultrasound. 2012;15(2):93-8. doi: 10.1016/j.jus.2012.02.007. [PubMed: 23396684].

  • 13.

    Cosgrove DO, Kedar RP, Bamber JC, al-Murrani B, Davey JB, Fisher C, et al. Breast diseases: color Doppler US in differential diagnosis. Radiology. 1993;189(1):99-104. doi: 10.1148/radiology.189.1.8372225. [PubMed: 8372225].

  • 14.

    Cosgrove DO, Bamber JC, Davey JB, McKinna JA, Sinnett HD. Color Doppler signals from breast tumors. Work in progress. Radiology. 1990;176(1):175-80. doi: 10.1148/radiology.176.1.2191364. [PubMed: 2191364].

  • 15.

    Stanzani D, Chala LF, Barros N, Cerri GG, Chammas MC. Can Doppler or contrast-enhanced ultrasound analysis add diagnostically important information about the nature of breast lesions?. Clinics (Sao Paulo). 2014;69(2):87-92. doi: 10.6061/clinics/2014(02)03. [PubMed: 24519198].

  • Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited